![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, April 10, 2016 4:28:00 PM
Viaderma's technologies and methods have numerous applications in pharmaceuticals, neutraceuticals, cosmetics, cannabis extract formulations, and many other things, and so forthcoming deals with any number of companies in these industries to make more effective and affordable medicines and products to meet the needs of consumers is the ultimate goal of Viaderma. The business model is to license this advanced transdermal technology, which by all accounts is efficacious, effective and sound. And that is why it's actively being implemented in a number of formulations that have great potential for future consumer products, over the counter treatments and pharmaceutical medications. It is believed that these efforts and subsequent licensing deals will result in substantial licensing revenues. The projections all point to a tremendous growth phase for this company.
FEATURED Mawson Finland Limited Expands Known Mineralized Zones at Rajapalot: New Lens Intercepts 21.75 m at 5.25 g/t Gold & 515 ppm Cobalt • Sep 4, 2024 9:02 AM
FEATURED Integrated Ventures Acquires 51% Stake In GetTrim.Com (TM), Telemedicine Platform With Focus On Expansion Into Booming GLP-1 Powered Weight Loss Market • Sep 4, 2024 8:45 AM
VAYK Confirms Receiving Revenue from First Airbnb Property with 1.4 Million Annual Revenue Goal • VAYK • Sep 4, 2024 9:34 AM
Avant Technologies Announces Strategic Review Process Intended to Maximize Shareholder Value • AVAI • Sep 4, 2024 8:00 AM
PickleJar Launches National "Get on the Bus" Campaign, Unveils Thompson Square Tour Bus Wrap • PKLE • Sep 4, 2024 7:17 AM
Maybacks Global and Inventel Products To Launch Global 24 Hour Shopping Channel • AHRO • Sep 3, 2024 9:15 AM